Circulating anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis and chronic obstructive pulmonary disease

Rheumatology International

Volumn 34, Issue 7, 2014, Pages 971-977

  Yang, Deng Ho ^a,b   Tu, Chuan Chou ^b   Wang, Shou Cheng ^b   Wei, Cheng Chung ^a,c   Cheng, Ya Wen ^a,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anti CCP antibody; Chronic pulmonary obstructive disease; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADOLESCENT; AGED; ANTIBODY PRODUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SMOKING; ADULT; ARTHRITIS, RHEUMATOID; BLOOD; DISEASE COURSE; IMMUNOLOGY; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHEUMATOID FACTOR; SEROEPIDEMIOLOGIC STUDIES; SMOKING;

EID: 84903273602     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2926-6     Document Type: Article

References (37)

1. Barra L, Pope J, Bessette L, Haraoui B, Bykerk V (2011) Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review. Rheumatology (Oxford) 50:311-316
2. Szodoray P, Szabo Z, Kapitany A et al (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 9:140-143
3. Wiik AS, van Venrooij WJ, Pruijn GJ (2010) All you wanted to know about anti-CP but were afraid to ask. Autoimmun Rev 10:90-93
4. Kokkonen H, Mullazehi M, Berglin E et al (2011) Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthr Res Ther 13:R13
5. Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthr Rheum 48:2741-2749 (Pubitemid 37280601)
6. Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376:1094-1108
7. Svard A, Kastbom A, Soderlin MK, Reckner-Olsson A, Skogh T (2011) A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis. J Rheumatol 38:1265-1272
8. Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, da Rosa Utiyama SR (2011) Association of anticyclic citrullinated peptide antibodies with extra-articular manifestations, gender, and tabagism in rheumatoid arthritis patients from southern Brazil. Clin Rheumatol 30:975-980
9. Young KA, Deane KD, Derber LA et al. (2013) Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies which are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. Arthr Rheum 65:1995-2004
10. Burr ML, Viatte S, Bukhari M et al (2012) Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis. Arthr Res Ther 14:R109
11. Lima I, Santiago M (2010) Antibodies against cyclic citrullinated peptides in infectious diseases - a systematic review. Clin Rheumatol 29:1345-1351
12. Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC (2010) Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthr Rheum 62:369-377
13. Mahdi H, Fisher BA, Kallberg H et al (2009) Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 41:1319-1324
14. Pistelli R, Ferrara L, Misuraca C, Bustacchini S (2011) Practical management problems of stable chronic obstructive pulmonary disease in the elderly. Curr Opin Pulm Med 17(Suppl 1): S43-S48
15. Brusselle GG, Joos GF, Bracke KR (2011) New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378:1015-1026
16. Tsoumakidou M, Tzanakis N, Kyriakou D, Chrysofakis G, Siafakas NM (2004) Inflammatory cell profiles and T-lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma. Clin Exp Allergy 34:234-240 (Pubitemid 38315260)
17. Vaguliene N, Zemaitis M, Lavinskiene S, Miliauskas S, Sakalauskas R (2013) Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease. BMC Immunol 14:36
18. Kilsgard O, Andersson P, Malmsten M et al (2012) Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide L-37, resulting in altered activities. Am J Respir Cell Mol Biol 46:240-248
19. Reynisdottir G, Karimi R, Joshua V et al (2013) Structural lung changes and local anti-citrulline immunity are early features of anti citrullinated-proteins antibodies positive rheumatoid arthritis. Arthr Rheum
20. Wood AM, de Pablo P, Buckley CD, Ahmad A, Stockley RA (2011) Smoke exposure as a determinant of autoantibody titre in alpha(1)-antitrypsin deficiency and COPD. Eur Respir J 37:32-38
21. Newkirk MM, Mitchell S, Procino M et al (2012) Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung disease. Eur J Immunol 42:1051-1061
22. Ruiz-Esquide V, Gomara MJ, Peinado VI et al (2012) Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol 31:1047-1050
23. Fischer A, Solomon JJ, du Bois RM et al (2012) Lung disease with anti-CP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 106:1040-1047
24. Klareskog L, Stolt P, Lundberg K et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLADR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthr Rheum 54:38-46
25. Makrygiannakis D, Hermansson M, Ulfgren AK et al (2008) Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67:1488-1492
26. Kallberg H, Padyukov L, Plenge RM et al (2007) Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 80:867-875 (Pubitemid 46668455)
27. Michou L, Teixeira VH, Pierlot C et al (2008) Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 67:466-470 (Pubitemid 351498425)
28. Oliveira RD, Junta CM, Oliveira FR, Silva LM, Donadi EA, Louzada-Junior P (2008) Share epitope, citrullinated cyclic peptide antibodies and smoking in Brazilian rheumatoid arthritis patients. Clin Rev Allergy Immunol 34:32-35
29. Klareskog L, Padyukov L, Alfredsson L (2007) Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19:49-54 (Pubitemid 44885727)
30. Fan LY, He DY, Wang Q et al (2012) Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis. Scand J Rheumatol 41:354-358
31. Vignola MB, Davila S, Cremonezzi D, Simes JC, Palma JA, Campana VR (2012) Evaluation of inflammatory biomarkers associated with oxidative stress and histological assessment of magnetic therapy on experimental myopathy in rats. Electromagn Biol Med 31:320-332
32. Jonsson T, Thorsteinsson J, Valdimarsson H (1998) Does smoking stimulate rheumatoid factor production in non-rheumatic individuals? APMIS 106:970-974 (Pubitemid 28512149)
33. Hayahara C, Ikeda K, Sakanishi Y, Ota T (2010) Incidence of serum rheumatoid factors in elder non-rheumatic individuals. Rinsho Byori 58:211-215
34. Korpilahde T, Heliovaara M, Knekt P, Marniemi J, Aromaa A, Aho K (2004) Smoking history and serum cotinine and thiocyanate concentrations as determinants of rheumatoid factor in nonrheumatoid subjects. Rheumatology (Oxford) 43:1424-1428 (Pubitemid 39480932)
35. Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG (2012) Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ 345:e5244
36. Masdottir B, Jonsson T, Manfredsdottir V, Vikingsson A, Brekkan A, Valdimarsson H (2000) Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 39:1202-1205
37. Cader MZ, Filer AD, Buckley CD, Raza K (2010) The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis. BMC Musculoskelet Disord 11:187